Skip to main content
Log in

Complementary and alternative medicine use in patients with hematological cancers in Malaysia

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Background

Complementary and alternative medicine (CAM) is often used by cancer patients, but not many studies had been published on the prevalence of CAM use in patients with hematological cancers. This study aims to determine the prevalence of CAM and type of CAM used in this group of patients in a multiracial and multicultural country.

Patients and methods

This is a cross-sectional survey carried out in two hospitals in Malaysia. Patients with underlying hematological cancers were asked to complete the questionnaires on CAM and the Hospital Anxiety and Depression Scale.

Results

A total of 245 patients participated. The prevalence of CAM use was 70.2 %. The most common types of CAM used are biological-based therapies (90.2 %) and mind-body interventions (42 %). Vitamin and diet supplements (68.6 %) and folk/herb remedies (58 %) are the most common biological-based therapies used. There is no significant association of CAM use with age, gender, education level, and household income. Female patients are more likely to use more than one CAM therapies. The most common reason reported for CAM use was to boost immunity (57 %) and cure (24 %). Majority of patients (65 %) felt CAM was effective, and 60 % did not inform their physicians regarding CAM usage.

Conclusion

In view of the high prevalence of CAM use in patients with hematological cancers, it is important that the physicians play an active role in seeking information from patients and to monitor possible drug-vitamin-herbal interactions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Barnes PM, Powell-Griner E, McFann K, Nahin RL (2004) Complementary and alternative medicine use among adults: United States 2002. Semin Integr Med 2:54–71

    Article  Google Scholar 

  2. Shmueli A, Shuval J (2006) Complementary and alternative medicine: beyond users and nonusers. Complement Ther Med 14(4):261–267

    Article  PubMed  Google Scholar 

  3. Yamashita H, Tsukayama H, Sugishita C (2002) Popularity of complementary and alternative medicine in Japan; a telephone survey. Complement Ther Med 10(2):89–93

    Article  Google Scholar 

  4. Reily D (2001) Comments on complementary and alternative medicine in Europe. J Altern Complement Med 7(suppl):s23–s31

    Article  Google Scholar 

  5. Nahin RL, Barnes PM, Stussman BJ, Bloom B (2009) Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States 2007. Natl Health Stat Rep 18:1–14

    Google Scholar 

  6. Hyodo I, Amano N, Egichi K et al (2005) Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin Oncol 23:2645–2652

    Article  PubMed  Google Scholar 

  7. Anderson J, Taylor A (2012) Use of complementary therapies for cancer symptom management: results of the 2007 nation health interview survey. J Altern Complement Med 18:235–241

    Article  PubMed Central  PubMed  Google Scholar 

  8. Horneber M, Bueschel G, Dennert G et al (2012) How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther 11:187–203

    Article  PubMed  Google Scholar 

  9. Shin JY, Kim SY, Park B et al (2012) Predictors of complementary and alternative medicine use in cancer care: results of a nationwide multicenter survey in Korea. Evid Based Complement Alternat Med. doi:10.1155/2012/212386

    Google Scholar 

  10. Chang KH, Brodie R, Choong MA et al (2011) Complementary and alternative medicine use in oncology: a questionnaire survey of patients and health care professionals. BMC Cancer 11:196

    Article  PubMed Central  PubMed  Google Scholar 

  11. Chow WH, Chang P, Lee SC et al (2010) Complementary and alternative medicine among Singapore cancer patients. Ann Acad Med Singap 39:129–135

    PubMed  Google Scholar 

  12. Shih V, Chinag JYL, Chan A (2009) Complementary and alternative medicine (CAM) usage in Singaporean adult cancer patients. Ann Oncol 20:752–757

    Article  CAS  PubMed  Google Scholar 

  13. Huebner J, Prott FR, Micke O et al (2014) Online survey of cancer patients on complementary and alternative medicine. Oncol Res Treat 37:304–308

    PubMed  Google Scholar 

  14. Al-Naggar RA, Bobryshev YV, Abdulghani M et al (2013) Complementary/alternative medicine use among cancer patients in Malaysia. World J Med Sci 8(2):157–164

    Google Scholar 

  15. Soraya HS, Suhaina S, Nor AE (2011) The use of complementary and alternative medicine therapy among Malay breast cancer survivors. Altern Ther Health Med 17:50–56

    Google Scholar 

  16. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370

    Article  CAS  PubMed  Google Scholar 

  17. Lua PL, Wong SY. The reliability of Malay version of Hospital anxiety depression scale (HADS) and McGuill quality of life (MQOL) among a group of patients with cancer in Malaysia. MJP

  18. Zheng LL, Wang YL, Li HC (2003) Utility of hospital anxiety and depression scale in the general hospital. Shanghai Arch Psychiatry 15:246–266

    Google Scholar 

  19. Perlman A, Lontok O, Huhmann M et al (2012) Prevalence and correlates of postdiagnosis initiation of complementary and alternative medicine among patients at a comprehensive cancer center. J Oncol Pract 9(1):34–43

    Article  PubMed Central  Google Scholar 

  20. Siti ZM, Tahir A, Ida Farah A et al (2009) Use of traditional and complementary medicine in Malaysia: a baseline study. Complement Ther Med 17:292–299

    Article  CAS  PubMed  Google Scholar 

  21. Barnes PM, Bloom B, Nahin RL (2008) Complementary and alternative medicine use among adults and children: United States 2007. Natl Health Stat Rep 12:1–23

    Google Scholar 

  22. Wanikiat P, Panthong A, Sujayanon P et al (2008) The anti-inflammatory effects and the inhibition of neutrophil responsiveness by Baleria lupulina and Clinacanthus nutans extract. J Ethnopharmacol 116:234–244

    Article  PubMed  Google Scholar 

  23. Kunsurn P, Ruangrungsi N, Lippun V et al (2013) The identities and anti-herpes simplex virus activities of Clinacanthus nutans and Clinacanthus siemensis. Asian Pac J Trop Biomed 3:284–290

    Article  Google Scholar 

  24. Ching SM, Zakaria ZA, Paimin F, Jalalian M (2013) Complementary alternative medicine use among patients with type 2 diabetes mellitus in the primary care setting: a cross sectional study in Malaysia. BMC Complement Altern Med 13:148

    Article  PubMed Central  PubMed  Google Scholar 

  25. Yong YK, Tan JJ, Teh SS et al (2013) Clinacanthus nutans extracts are antioxidant with antiproliferative effect on cultured human cancer cell lines. Evid Based Complement Alternat Med 2013:462751. doi:10.1155/2013/462751

    Article  PubMed Central  PubMed  Google Scholar 

  26. Riley B, Perna R, Tate D et al (1998) Types of spiritual wellbeing among patients with chronic illness: their relations to various forms of quality of life. Arch Phys Med Rehabil 79:258–264

    Article  CAS  PubMed  Google Scholar 

  27. Garssen B, Uwland-Sikkema NF, Visser A. How spirituality helps cancer patients with the adjustment to their disease. J Relig Health DOI: 10.1007/s10943-014-9864-9

  28. Kremser T, Evans A, Moore A et al (2008) Use of complementary therapies by Australian women with breast cancer. Breast 17:387–394

    Article  CAS  PubMed  Google Scholar 

  29. Yang C, Chien LY, Tai CJ (2008) Use of complementary and alternative medicine among patients with cancer receiving outpatient chemotherapy in Taiwan. J Altern Complement Med 14:413–416

    Article  PubMed  Google Scholar 

  30. Gupta D, Lis CG, Birdsall TC, Grutsch JF (2005) The use of dietary supplements in a community hospital comprehensive cancer center: implications for conventional cancer care. Support Care Cancer 11:912–919

    Article  Google Scholar 

  31. Lee AH, Ingraham SE, Kopp M, Foraida MI, Jazieh AR (2006) The incidence of potential interactions between dietary supplements and prescription medications in cancer patients at a Veterans Administration Hospital. Am J Clin Oncol 29:178–182

    Article  CAS  PubMed  Google Scholar 

  32. Niggemann B, Gruber C (2003) Side-effects of complementary and alternative medicine. Allergy 58:707–716

    Article  CAS  PubMed  Google Scholar 

  33. Parize P, Angebault C, de Fonbrune FSO et al (2013) Naturopathy as a potential source of mould infections in patients with hematological malignancies. J Hosp Infect 85:163–164

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to thank SN Lee Hong Lean who assisted in the recruitment of patients and also Dr Haris Rahman and Dr Ng Soo Chin for agreeing to allow their patients to participate in this study. This study is funded by the UM HIR grant E–000008–20001.

Conflict of interest

The authors have no conflict of interest in the content of the study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. G. Gan.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gan, G.G., Leong, Y.C., Bee, P.C. et al. Complementary and alternative medicine use in patients with hematological cancers in Malaysia. Support Care Cancer 23, 2399–2406 (2015). https://doi.org/10.1007/s00520-015-2614-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-015-2614-z

Keywords

Navigation